This episode demystifies the critical process of authenticating FDA export documents, such as the Certificate to Foreign Government (FSC/CFG), for international markets. We explore the difference between an apostille and full legalization, explain why foreign regulators require this step, and detail the impact of the FDA's transition to electronic certificates as of January 2, 2024. Learn the new rules and procedures to ensure your medical device shipments aren't delayed at the border.
Key Questions:
• What is the difference between an apostille and legalization?
• Which countries require an apostille for my Certificate to Foreign Government?
• How did the FDA's switch to electronic certificates on January 2, 2024, change the process?
• Why do I need to print my electronic certificate in color?
• What is the FDA's new QR code validation system (FECV)?
• Does the new FDA validator replace the need for an apostille?
• What is the multi-step process for countries not part of the Hague Convention?
• Who issues the apostille for federal documents in the United States?
Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
